Mar 24, 2009
Additional funding through shares emission and warrant scheme

Lytix Biopharma has issued shares and a warrant directed at North Murray AS / Gert W. Munthe

The Board of Lytix Biopharma AS decided on Friday 20th March 2009 to issue 850 shares at value NOK 600 each to the company North Murray AS (wholly owned by Mr. Gert W. Munthe and family). In addition the Board, using the remains of the previously authorised shares issue limits, has issued a warrant to North Murray AS for the purchase of an additional 23.622 shares at NOK 600 value. The warrant expires on 22nd May 2009.  If exercised the net proceeds to Lytix Biopharma will be NOK 14.173.200.

For further information contact:

Chairman of the Board, Knut Eidissen (+47 916 17 707)

CEO Gunnar Sælid (+47 911 92 330)